FOLD
Amicus Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$14.49
+0.00%Margins
Gross margin
87.9%
EBITDA margin
8.5%
EBIT margin
5.2%
Net margin
-4.3%
FCF margin
4.7%
-9.9%
Return on equity
-2.9%
Return on assets
4.3%
Return on invested capital
0.70x
Asset turnover
$33.1M
Cash from operations
$0.95
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025